Global Cancer Nanomedicine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Cancer Nanomedicine market size was valued at US$ 218570 million in 2024 and is forecast to a readjusted size of USD 443050 million by 2031 with a CAGR of 10.7% during review period.

Nanomedicine is a branch of nanotechnology that uses nanoparticles to diagnose, treat, monitor, and control biological systems. By manipulating materials at the nanoscale, it improves medicine delivery. As a result, nanomedicine has helped treat a wide range of diseases. Nanomedicine is still in its infancy, with numerous products in the works. Nanobiotix has identified 230 nanomedicine products that are either patented or in the early stages of development. 49 of the 230 products are on the market, while the remaining 122 are in clinical trials, either in Phase II or Phase III trials.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report is a detailed and comprehensive analysis for global Cancer Nanomedicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Cancer Nanomedicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Cancer Nanomedicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Cancer Nanomedicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Cancer Nanomedicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Cancer Nanomedicine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Cancer Nanomedicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam Pharmaceuticals, Inc, Amgen Inc, Arrowhead Pharmaceuticals, Inc, AstraZeneca, Cadila Pharmaceuticals, CELGENE CORPORATION, Celsion Corporation, Genzyme, Merck & Co., Inc, Nippon Kayaku Co.,Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Cancer Nanomedicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Inorganic Nanoparticles

Protein Nanoparticles

Polymer Nanoparticles

Lipid Organic Nanoparticles

Market segment by Application

Breast Cancer

Pancreatic Cancer

Brain Cancer

Lung Cancer

Other

Major players covered

Alnylam Pharmaceuticals, Inc

Amgen Inc

Arrowhead Pharmaceuticals, Inc

AstraZeneca

Cadila Pharmaceuticals

CELGENE CORPORATION

Celsion Corporation

Genzyme

Merck & Co., Inc

Nippon Kayaku Co.,Ltd

Nanobiotix

Pfizer Inc

F. Hoffmann-La Roche Ltd

Takeda Pharmaceutical Company Limited

General Electric

Johnson & Johnson Services, Inc

Teva Pharmaceutical Industries Ltd

Gilead Sciences, Inc

Novartis AG

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Cancer Nanomedicine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Cancer Nanomedicine, with price, sales quantity, revenue, and global market share of Cancer Nanomedicine from 2020 to 2025.

Chapter 3, the Cancer Nanomedicine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Cancer Nanomedicine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cancer Nanomedicine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Nanomedicine.

Chapter 14 and 15, to describe Cancer Nanomedicine sales channel, distributors, customers, research findings and conclusion.